John E. Niederhuber

[3] In addition to his management of NCI, Dr. Niederhuber remained involved in research, through his laboratory on the National Institutes of Health campus.

He is recognized for his pioneering work in hepatic artery infusion chemotherapy and was the first to demonstrate the feasibility of totally implantable vascular access devices.

Dr. Niederhuber was NCI's Chief Operating Officer and deputy director for Translational and Clinical Sciences, a position he assumed in September 2005.

Before joining the Institute in a full-time capacity, Dr. Niederhuber was a Professor of Surgery and Oncology at the University of Wisconsin School of Medicine.

Dr. Niederhuber is a graduate of Bethany College in West Virginia and the Ohio State University School of Medicine.

He was an NIH Academic Trainee in Surgery at the University of Michigan from 1969 to 1970 and was a visiting fellow in the Division of Immunology at The Karolinska Institute in Stockholm, Sweden from 1970 to 1971.

During 1986 and 1987, he was visiting professor in the Department of Molecular Biology and Genetics at The Johns Hopkins University School of Medicine in Baltimore, Md.

Dr. Niederhuber joined the faculty at Johns Hopkins in 1987 as Professor of Surgery, Oncology, and Molecular Biology and Genetics.

He has authored and coauthored more than 180 publications and edited four books, including (with distinguished colleagues) the reference text Clinical Oncology, currently[as of?]